MarketBeat Instant News Alerts 2 hours agoB. Riley Lifts Earnings Estimates for Viridian TherapeuticsMarketBeatViridian Therapeutics, Inc. (NASDAQ:VRDN - Free Report) - B. Riley upped their Q2 2025 EPS estimates for Viridian Therapeutics in a research note issued on Tuesday, May 6th. B. Riley analyst K. Patel now forecasts that the company will post earnings per share of ($0.91) for the quarter, up from tNASDAQ:VRDNRead B. Riley Lifts Earnings Estimates for Viridian Therapeutics2 hours agoHC Wainwright Analysts Cut Earnings Estimates for VRDNMarketBeatViridian Therapeutics, Inc. (NASDAQ:VRDN - Free Report) - Research analysts at HC Wainwright dropped their Q2 2025 earnings estimates for shares of Viridian Therapeutics in a research report issued on Wednesday, May 7th. HC Wainwright analyst D. Tsao now anticipates that the company will earn ($1NASDAQ:VRDNRead HC Wainwright Analysts Cut Earnings Estimates for VRDN2 hours agoQ2 EPS Estimate for Viridian Therapeutics Cut by AnalystMarketBeatViridian Therapeutics, Inc. (NASDAQ:VRDN - Free Report) - Investment analysts at Leerink Partnrs lowered their Q2 2025 earnings per share (EPS) estimates for shares of Viridian Therapeutics in a note issued to investors on Tuesday, May 6th. Leerink Partnrs analyst T. Smith now expects that the coNASDAQ:VRDNRead Q2 EPS Estimate for Viridian Therapeutics Cut by Analyst2 hours agoQ2 EPS Forecast for Viridian Therapeutics Boosted by AnalystMarketBeatViridian Therapeutics, Inc. (NASDAQ:VRDN - Free Report) - Investment analysts at Wedbush increased their Q2 2025 earnings per share estimates for Viridian Therapeutics in a research note issued on Tuesday, May 6th. Wedbush analyst L. Chico now anticipates that the company will post earnings per sNASDAQ:VRDNRead Q2 EPS Forecast for Viridian Therapeutics Boosted by Analyst2 hours agoLeerink Partnrs Has Bullish Estimate for VRTX Q2 EarningsMarketBeatVertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) - Investment analysts at Leerink Partnrs raised their Q2 2025 earnings per share estimates for shares of Vertex Pharmaceuticals in a research note issued on Tuesday, May 6th. Leerink Partnrs analyst D. Risinger now expects that the pNASDAQ:VRTXRead Leerink Partnrs Has Bullish Estimate for VRTX Q2 Earnings2 hours agoWhat is Leerink Partnrs' Forecast for VYGR Q2 Earnings?MarketBeatVoyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) - Stock analysts at Leerink Partnrs cut their Q2 2025 earnings per share (EPS) estimates for Voyager Therapeutics in a report released on Tuesday, May 6th. Leerink Partnrs analyst L. Nsongo now expects that the company will post earnings of (NASDAQ:VYGRRead What is Leerink Partnrs' Forecast for VYGR Q2 Earnings? Trending News1BROOKFIELD Corp ON Boosts Stock Holdings in TC Energy Co. (NYSE:TRP)2Wolfspeed (NYSE:WOLF) Shares Gap Up - What's Next?3Whitecap Resources Inc. Sells 619,983 Shares of Whitecap Resources Inc. (TSE:WCP) Stock4Intel (NASDAQ:INTC) Shares Up 2.6% - Here's Why5Centiva Capital LP Acquires 462,218 Shares of QuantumScape Co. (NYSE:QS)6Quantum Computing (NASDAQ:QUBT) Shares Gap Down - Should You Sell?7Ameriprise Financial Inc. Has $407.16 Million Stock Position in Cintas Co. (NASDAQ:CTAS)8NU (NU) to Release Quarterly Earnings on Tuesday All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoWedbush Equities Analysts Boost Earnings Estimates for VYGRMarketBeatNASDAQ:VYGRRead Wedbush Equities Analysts Boost Earnings Estimates for VYGR2 hours agoWhat is Seaport Res Ptn's Forecast for WCN Q2 Earnings?MarketBeatNYSE:WCNRead What is Seaport Res Ptn's Forecast for WCN Q2 Earnings?2 hours agoWilliam Blair Issues Optimistic Outlook for Zoetis EarningsMarketBeatNYSE:ZTSRead William Blair Issues Optimistic Outlook for Zoetis Earnings2 hours agoLeerink Partnrs Has Positive Estimate for AMLX Q1 EarningsMarketBeatNASDAQ:AMLXRead Leerink Partnrs Has Positive Estimate for AMLX Q1 Earnings2 hours agoLeerink Partnrs Has Bullish Forecast for PTCT Q1 EarningsMarketBeatNASDAQ:PTCTRead Leerink Partnrs Has Bullish Forecast for PTCT Q1 Earnings2 hours agoWilliam Blair Lifts Earnings Estimates for PTC TherapeuticsMarketBeatNASDAQ:PTCTRead William Blair Lifts Earnings Estimates for PTC Therapeutics2 hours agoChevron (NYSE:CVX) Shares Sold Off Rep. Robert Bresnahan, Jr.MarketBeatNYSE:CVXRead Chevron (NYSE:CVX) Shares Sold Off Rep. Robert Bresnahan, Jr.2 hours agoAmazon.com (NASDAQ:AMZN) Stock Acquired Rep. Robert Bresnahan, Jr.MarketBeatNASDAQ:AMZNRead Amazon.com (NASDAQ:AMZN) Stock Acquired Rep. Robert Bresnahan, Jr.2 hours agoRep. Robert Bresnahan, Jr. Buys PepsiCo, Inc. (NASDAQ:PEP) StockMarketBeatNASDAQ:PEPRead Rep. Robert Bresnahan, Jr. Buys PepsiCo, Inc. (NASDAQ:PEP) Stock2 hours agoRep. Robert Bresnahan, Jr. Purchases Shares of United Parcel Service, Inc. (NYSE:UPS)MarketBeatNYSE:UPSRead Rep. Robert Bresnahan, Jr. Purchases Shares of United Parcel Service, Inc. (NYSE:UPS)2 hours agoMicrosoft (NASDAQ:MSFT) Stock Acquired Rep. Robert Bresnahan, Jr.MarketBeatNASDAQ:MSFTRead Microsoft (NASDAQ:MSFT) Stock Acquired Rep. Robert Bresnahan, Jr.2 hours agoMicron Technology (NASDAQ:MU) Stock Unloaded Rep. Robert Bresnahan, Jr.MarketBeatNASDAQ:MURead Micron Technology (NASDAQ:MU) Stock Unloaded Rep. Robert Bresnahan, Jr.2 hours agoEllevest Inc. Sells 5,080 Shares of AstraZeneca PLC (NASDAQ:AZN)MarketBeatNASDAQ:AZNRead Ellevest Inc. Sells 5,080 Shares of AstraZeneca PLC (NASDAQ:AZN)2 hours agoEllevest Inc. Sells 605 Shares of HubSpot, Inc. (NYSE:HUBS)MarketBeatNYSE:HUBSRead Ellevest Inc. Sells 605 Shares of HubSpot, Inc. (NYSE:HUBS)2 hours agoEllevest Inc. Has $1.52 Million Stock Position in Sony Group Co. (NYSE:SONY)MarketBeatNYSE:SONYRead Ellevest Inc. Has $1.52 Million Stock Position in Sony Group Co. (NYSE:SONY)2 hours agoNovartis AG (NYSE:NVS) Shares Sold by Ellevest Inc.MarketBeatNYSE:NVSRead Novartis AG (NYSE:NVS) Shares Sold by Ellevest Inc.2 hours agoEllevest Inc. Has $1.78 Million Stock Holdings in DoorDash, Inc. (NASDAQ:DASH)MarketBeatNASDAQ:DASHRead Ellevest Inc. Has $1.78 Million Stock Holdings in DoorDash, Inc. (NASDAQ:DASH)2 hours agoEllevest Inc. Raises Stake in Blackstone Inc. (NYSE:BX)MarketBeatNYSE:BXRead Ellevest Inc. Raises Stake in Blackstone Inc. (NYSE:BX)2 hours agoEllevest Inc. Has $3.18 Million Stock Holdings in SAP SE (NYSE:SAP)MarketBeatNYSE:SAPRead Ellevest Inc. Has $3.18 Million Stock Holdings in SAP SE (NYSE:SAP)2 hours agoElliott Investment Management L.P. Trims Holdings in Arm Holdings plc (NASDAQ:ARM)MarketBeatNASDAQ:ARMRead Elliott Investment Management L.P. Trims Holdings in Arm Holdings plc (NASDAQ:ARM)2 hours agoElliott Investment Management L.P. Buys 1,320,109 Shares of CorMedix Inc. (NASDAQ:CRMD)MarketBeatNASDAQ:CRMDRead Elliott Investment Management L.P. Buys 1,320,109 Shares of CorMedix Inc. (NASDAQ:CRMD)2 hours agoHDFC Bank Limited (NYSE:HDB) Shares Bought by Elliott Investment Management L.P.MarketBeatNYSE:HDBRead HDFC Bank Limited (NYSE:HDB) Shares Bought by Elliott Investment Management L.P.2 hours agoElliott Investment Management L.P. Has $433.06 Million Stock Holdings in NRG Energy, Inc. (NYSE:NRG)MarketBeatNYSE:NRGRead Elliott Investment Management L.P. Has $433.06 Million Stock Holdings in NRG Energy, Inc. (NYSE:NRG)2 hours agoSouthwest Airlines Co. (NYSE:LUV) Stock Position Trimmed by Elliott Investment Management L.P.MarketBeatNYSE:LUVRead Southwest Airlines Co. (NYSE:LUV) Stock Position Trimmed by Elliott Investment Management L.P. Featured Articles and OffersWhy Wells Fargo Is Buying $40 Billion of Its Own StockBy Gabriel Osorio-Mazilli | May 6, 2025View Why Wells Fargo Is Buying $40 Billion of Its Own StockBuffett’s favorite chart just hit 209% – here’s what that means for goldFrom Golden Portfolio(Ad)View Buffett’s favorite chart just hit 209% – here’s what that means for goldRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsBy Ryan Hasson | May 5, 2025View Rocket Lab Braces for Q1 Earnings Amid Soaring Expectations3 Mid-Cap Medical Stocks Outperforming the MarketBy Ryan Hasson | May 6, 2025View 3 Mid-Cap Medical Stocks Outperforming the Market5 Stocks That Crushed Earnings and Guidance ForecastsBy Thomas Hughes | May 8, 2025View 5 Stocks That Crushed Earnings and Guidance ForecastsThe Robotics Revolution has arrived … and one $7 stock could take off as a result.From Weiss Ratings(Ad)View The Robotics Revolution has arrived … and one $7 stock could take off as a result.Cantor Equity Partners, Inc. Class A Ordinary Shares (NASDAQ:CEP) Sees Strong Trading Volume - Still a Buy?By MarketBeat | May 8, 2025View Cantor Equity Partners, Inc. Class A Ordinary Shares (NASDAQ:CEP) Sees Strong Trading Volume - Still a Buy?Tempus AI Stock: Time to Double Down or Cut and Run?By Thomas Hughes | May 8, 2025View Tempus AI Stock: Time to Double Down or Cut and Run? Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
